Taiwanese Pharmaceuticals & Biotech Most Popular Stocks

PharmaEssentia

Market Cap: NT$248.7b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Caliway Biopharmaceuticals

Market Cap: NT$209.7b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Lotus Pharmaceutical

Market Cap: NT$71.8b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$58.7b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Pell Bio-Med Technology

Market Cap: NT$38.7b

A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen receptor T cell (CAR-T), and other related services and products.

Center Laboratories

Market Cap: NT$33.1b

A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.

Lin BioScience

Market Cap: NT$32.7b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Lumosa Therapeutics

Market Cap: NT$26.2b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

Oneness Biotech

Market Cap: NT$25.5b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.

Polaris Group

Market Cap: NT$22.9b

Offers biotechnology, drug testing, and contract development and manufacturing services.

Sunmax Biotechnology

Market Cap: NT$21.5b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

HanchorBio

Market Cap: NT$20.9b

Operates as a biotechnology company that develops biologics for cancer patients.

TTY Biopharm

Market Cap: NT$20.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

EirGenix

Market Cap: NT$17.9b

Operates as a contract development and manufacturing company in Taiwan and internationally.

ScinoPharm Taiwan

Market Cap: NT$17.0b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.

Pharmasaga

Market Cap: NT$15.9b

A drug discovery and development company, focuses on developing anti-diabetic drugs.

Synmosa Biopharma

Market Cap: NT$15.7b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

AP Biosciences

Market Cap: NT$14.4b

Researches and develops protein and antibody drugs for unmet medical needs.

YungShin Global Holding

Market Cap: NT$14.2b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

TaiMed Biologics

Market Cap: NT$14.0b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

TCM Biotech International

Market Cap: NT$13.2b

A biotech company, engages in the research and development of drugs for liver diseases.

Alar Pharmaceuticals

Market Cap: NT$13.0b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Foresee Pharmaceuticals

Market Cap: NT$12.8b

Operates as biopharmaceutical company in the United States, China, and Europe.

Ever Supreme Bio Technology

Market Cap: NT$12.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.

Medigen Vaccine Biologics

Market Cap: NT$12.3b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Handa Pharmaceuticals

Market Cap: NT$12.3b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.

Tanvex BioPharma

Market Cap: NT$11.7b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.3b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

Elixiron Immunotherapeutics (Cayman)

Market Cap: NT$10.8b

Engages in the development of precision-targeted immunotherapy drugs in Shanghai, Taipei, the United States and Switzerland.

Gongwin Biopharm Holdings

Market Cap: NT$9.4b

A clinical-stage biopharmaceutical company, develops anticancer drugs in Hong Kong, China, and Singapore.

Uwell Biopharma

Market Cap: NT$8.9b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of novel cancer immunotherapeutic in Taiwan.

PharmaEngine

Market Cap: NT$8.5b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$8.4b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

Intelligene

Market Cap: NT$8.1b

Engages in the research and development of RNA gene therapy drugs in Taiwan and Australia.

Adimmune

Market Cap: NT$7.5b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Acepodia

Market Cap: NT$7.5b

Operates as a clinical stage biotechnology company.